{"id": "article-27956_0", "title": "Yersinia Pseudotuberculosis -- Continuing Education Activity", "content": "Yersinia pseudotuberculosis causes a food-borne infection characterized by self-limited mesenteric lymphadenitis that mimics appendicitis. This activity reviews the evaluation and management of Yersinia pseudotuberculosis and highlights the role of the interprofessional team in the care of patients with this condition.", "contents": "Yersinia Pseudotuberculosis -- Continuing Education Activity. Yersinia pseudotuberculosis causes a food-borne infection characterized by self-limited mesenteric lymphadenitis that mimics appendicitis. This activity reviews the evaluation and management of Yersinia pseudotuberculosis and highlights the role of the interprofessional team in the care of patients with this condition."}
{"id": "article-27956_1", "title": "Yersinia Pseudotuberculosis -- Continuing Education Activity", "content": "Objectives: Review the pathophysiology of Yersinia pseudotuberculosis. Outline the typical presentation of a patient with Yersinia pseudotuberculosis. Explain the recommended management of Yersinia pseudotuberculosis. Summarize interprofessional team strategies for improving care coordination and communication regarding the management of patients with Yersinia pseudotuberculosis. Access free multiple choice questions on this topic.", "contents": "Yersinia Pseudotuberculosis -- Continuing Education Activity. Objectives: Review the pathophysiology of Yersinia pseudotuberculosis. Outline the typical presentation of a patient with Yersinia pseudotuberculosis. Explain the recommended management of Yersinia pseudotuberculosis. Summarize interprofessional team strategies for improving care coordination and communication regarding the management of patients with Yersinia pseudotuberculosis. Access free multiple choice questions on this topic."}
{"id": "article-27956_2", "title": "Yersinia Pseudotuberculosis -- Introduction", "content": "The genus Yersinia comprises a group of gram-negative rod-shaped bacteria that are broadly distributed in the environment. This genus encompasses 17 different species of which 3 organisms are virulent to humans. These include Yersinia pestis , Yersinia enterocolitica , and Yersinia pseudotuberculosis . Both Y. enterocolitica and Y. pseudotuberculosis are known to cause an enteric illness; however, Y. pseudotuberculosis is\u00a0rare in humans compared to Y.\u00a0enterocolitica , which is more commonly seen. [1] [2] [3]", "contents": "Yersinia Pseudotuberculosis -- Introduction. The genus Yersinia comprises a group of gram-negative rod-shaped bacteria that are broadly distributed in the environment. This genus encompasses 17 different species of which 3 organisms are virulent to humans. These include Yersinia pestis , Yersinia enterocolitica , and Yersinia pseudotuberculosis . Both Y. enterocolitica and Y. pseudotuberculosis are known to cause an enteric illness; however, Y. pseudotuberculosis is\u00a0rare in humans compared to Y.\u00a0enterocolitica , which is more commonly seen. [1] [2] [3]"}
{"id": "article-27956_3", "title": "Yersinia Pseudotuberculosis -- Etiology", "content": "Yersinia pseudotuberculosis infection is usually acquired through the consumption of contaminated foods and water. Yersinia pseudotuberculosis is present in the soil and\u00a0can be seen in fresh farm-produced plants and root vegetables. It has numerous animal reservoirs and is abundant in wildlife, including birds, rodents, rabbits, deer, dogs, cats, and cattle. [2] [4] [5] The incubation period varies from 5 to 10 days. A latent period of 2 to 20 days has been reported, with peak incidence rates at 4 days after ingestion.", "contents": "Yersinia Pseudotuberculosis -- Etiology. Yersinia pseudotuberculosis infection is usually acquired through the consumption of contaminated foods and water. Yersinia pseudotuberculosis is present in the soil and\u00a0can be seen in fresh farm-produced plants and root vegetables. It has numerous animal reservoirs and is abundant in wildlife, including birds, rodents, rabbits, deer, dogs, cats, and cattle. [2] [4] [5] The incubation period varies from 5 to 10 days. A latent period of 2 to 20 days has been reported, with peak incidence rates at 4 days after ingestion."}
{"id": "article-27956_4", "title": "Yersinia Pseudotuberculosis -- Epidemiology -- United States", "content": "No specific pattern of Yersinia pseudotuberculosis infection has been reported. Most Yersinia outbreaks have been associated with Yersinia enterocolitica rather than Yersinia pseudotuberculosis .", "contents": "Yersinia Pseudotuberculosis -- Epidemiology -- United States. No specific pattern of Yersinia pseudotuberculosis infection has been reported. Most Yersinia outbreaks have been associated with Yersinia enterocolitica rather than Yersinia pseudotuberculosis ."}
{"id": "article-27956_5", "title": "Yersinia Pseudotuberculosis -- Epidemiology -- International", "content": "The distribution of Yersinia pseudotuberculosis infection is worldwide. Most cases occur in winter\u00a0due to enhanced growth characteristics in cold temperatures. Epidemics\u00a0due to Y. pseudotuberculosis have occurred in the Russian Far East, and Japan during the 2nd half of the 20th century causing the 'Far East Scarlet-like Fever'(FESLF). Y. pseudotuberculosis has a sporadic distribution in Europe. [5]", "contents": "Yersinia Pseudotuberculosis -- Epidemiology -- International. The distribution of Yersinia pseudotuberculosis infection is worldwide. Most cases occur in winter\u00a0due to enhanced growth characteristics in cold temperatures. Epidemics\u00a0due to Y. pseudotuberculosis have occurred in the Russian Far East, and Japan during the 2nd half of the 20th century causing the 'Far East Scarlet-like Fever'(FESLF). Y. pseudotuberculosis has a sporadic distribution in Europe. [5]"}
{"id": "article-27956_6", "title": "Yersinia Pseudotuberculosis -- Epidemiology -- Mortality/Morbidity", "content": "Yersinia pseudotuberculosis has a low case-fatality rate. However, the rare sepsis-associated illnesses caused by Y. pseudotuberculosis infection in patients with chronic liver disease has a mortality rate that exceeds 75%.", "contents": "Yersinia Pseudotuberculosis -- Epidemiology -- Mortality/Morbidity. Yersinia pseudotuberculosis has a low case-fatality rate. However, the rare sepsis-associated illnesses caused by Y. pseudotuberculosis infection in patients with chronic liver disease has a mortality rate that exceeds 75%."}
{"id": "article-27956_7", "title": "Yersinia Pseudotuberculosis -- Epidemiology -- Race", "content": "Yersinia pseudotuberculosis infection has no specific racial or ethnic predilection.", "contents": "Yersinia Pseudotuberculosis -- Epidemiology -- Race. Yersinia pseudotuberculosis infection has no specific racial or ethnic predilection."}
{"id": "article-27956_8", "title": "Yersinia Pseudotuberculosis -- Epidemiology -- Sex", "content": "Yersinia pseudotuberculosis infection is more\u00a0common in men than in women. The postinfectious complications of arthritis and erythema nodosum are more common in women than in men.", "contents": "Yersinia Pseudotuberculosis -- Epidemiology -- Sex. Yersinia pseudotuberculosis infection is more\u00a0common in men than in women. The postinfectious complications of arthritis and erythema nodosum are more common in women than in men."}
{"id": "article-27956_9", "title": "Yersinia Pseudotuberculosis -- Epidemiology -- Age", "content": "Seventy-five percent or more of patients with Yersinia pseudotuberculosis infection are ages five to 15 years.", "contents": "Yersinia Pseudotuberculosis -- Epidemiology -- Age. Seventy-five percent or more of patients with Yersinia pseudotuberculosis infection are ages five to 15 years."}
{"id": "article-27956_10", "title": "Yersinia Pseudotuberculosis -- Pathophysiology", "content": "The enteropathogen, Yersinia pseudotuberculosis, requires\u00a0a large inoculum to produce the disease.\u00a0The primary virulence factor is a plasmid-encoded protein that causes increased invasiveness. Yersinia pseudotuberculosis survives intracellularly.", "contents": "Yersinia Pseudotuberculosis -- Pathophysiology. The enteropathogen, Yersinia pseudotuberculosis, requires\u00a0a large inoculum to produce the disease.\u00a0The primary virulence factor is a plasmid-encoded protein that causes increased invasiveness. Yersinia pseudotuberculosis survives intracellularly."}
{"id": "article-27956_11", "title": "Yersinia Pseudotuberculosis -- Pathophysiology", "content": "Yersinia pseudotuberculosis inhabits and grows in the gastrointestinal tract, initially in the Peyer's patches, and then spreading to the liver and the spleen through the mesenteric lymph nodes or directly. [2]", "contents": "Yersinia Pseudotuberculosis -- Pathophysiology. Yersinia pseudotuberculosis inhabits and grows in the gastrointestinal tract, initially in the Peyer's patches, and then spreading to the liver and the spleen through the mesenteric lymph nodes or directly. [2]"}
{"id": "article-27956_12", "title": "Yersinia Pseudotuberculosis -- Pathophysiology", "content": "Yersinia pseudotuberculosis has a siderophore-mediated iron scavenging system that contributes to its virulence. [6] Patients with iron overload disorders like venous congestion, hemochromatosis, cirrhosis, and hemolytic anemias are, therefore, at a slightly higher risk for systemic infections. [7]", "contents": "Yersinia Pseudotuberculosis -- Pathophysiology. Yersinia pseudotuberculosis has a siderophore-mediated iron scavenging system that contributes to its virulence. [6] Patients with iron overload disorders like venous congestion, hemochromatosis, cirrhosis, and hemolytic anemias are, therefore, at a slightly higher risk for systemic infections. [7]"}
{"id": "article-27956_13", "title": "Yersinia Pseudotuberculosis -- Histopathology", "content": "In general, the appendix will appear normal, but the nearby mesenteric lymph nodes and Peyer's patches may show epithelioid granulomatous lesions, coagulative necrosis, and lymphoid hyperplasia, and can resemble tuberculosis. The small bowel may develop microabscesses, cryptic hyperplasia, and shortening of villi. Granulomatous abscesses form in organs like the liver, spleen, lungs, kidneys, and intestines when the organism spreads during sepsis. [8]", "contents": "Yersinia Pseudotuberculosis -- Histopathology. In general, the appendix will appear normal, but the nearby mesenteric lymph nodes and Peyer's patches may show epithelioid granulomatous lesions, coagulative necrosis, and lymphoid hyperplasia, and can resemble tuberculosis. The small bowel may develop microabscesses, cryptic hyperplasia, and shortening of villi. Granulomatous abscesses form in organs like the liver, spleen, lungs, kidneys, and intestines when the organism spreads during sepsis. [8]"}
{"id": "article-27956_14", "title": "Yersinia Pseudotuberculosis -- History and Physical", "content": "Y. pseudotuberculosis causes self-limiting acute gastroenteritis and mesenteric lymphadenitis that mimics acute appendicitis. Enteritis is usually seen in children as opposed to the mesenteric adenitis seen in adults. [5] Symptoms include abdominal pain, fever, vomiting, and diarrhea. The abdominal pain is often located in the right lower quadrant and may mimic appendicitis.", "contents": "Yersinia Pseudotuberculosis -- History and Physical. Y. pseudotuberculosis causes self-limiting acute gastroenteritis and mesenteric lymphadenitis that mimics acute appendicitis. Enteritis is usually seen in children as opposed to the mesenteric adenitis seen in adults. [5] Symptoms include abdominal pain, fever, vomiting, and diarrhea. The abdominal pain is often located in the right lower quadrant and may mimic appendicitis."}
{"id": "article-27956_15", "title": "Yersinia Pseudotuberculosis -- History and Physical", "content": "Other problems associated with Yersinia pseudotuberculosis infection include terminal ileitis and intussusception, more commonly in children. In most cases, enterocolitis lasts one to three weeks. Erythema nodosum, arthralgias, reactive arthritis, ankylosing spondylitis, and lumbar facet joint disease can occur. A sporotrichoid pattern of disease has been associated with Yersinia pseudotuberculosis infection. Cutaneous manifestations include erythema of the face and neck, conjunctival hyperemia, strawberry tongue, punctate skin rash, and desquamation. Ophthalmic findings such as uveitis and conjunctivitis have also been reported. Physical findings caused by Yersinia pseudotuberculosis infection may be grouped into three main categories: systemic, enteric, and rheumatologic.", "contents": "Yersinia Pseudotuberculosis -- History and Physical. Other problems associated with Yersinia pseudotuberculosis infection include terminal ileitis and intussusception, more commonly in children. In most cases, enterocolitis lasts one to three weeks. Erythema nodosum, arthralgias, reactive arthritis, ankylosing spondylitis, and lumbar facet joint disease can occur. A sporotrichoid pattern of disease has been associated with Yersinia pseudotuberculosis infection. Cutaneous manifestations include erythema of the face and neck, conjunctival hyperemia, strawberry tongue, punctate skin rash, and desquamation. Ophthalmic findings such as uveitis and conjunctivitis have also been reported. Physical findings caused by Yersinia pseudotuberculosis infection may be grouped into three main categories: systemic, enteric, and rheumatologic."}
{"id": "article-27956_16", "title": "Yersinia Pseudotuberculosis -- History and Physical", "content": "Systemic findings include jaundice, hypotension, and lymphadenopathy Enteric findings include abdominal tenderness with or without rebound over McBurney point Rheumatologic involvement\u00a0includes joint effusion, tenderness, or decreased range of movement and may be asymmetric in distribution. Patients with immunosuppression\u00a0and iron-overload states such as hemochromatosis, venous congestion, hemolytic anemia, and cirrhosis are at risk for sepsis. [9] [10] [11]", "contents": "Yersinia Pseudotuberculosis -- History and Physical. Systemic findings include jaundice, hypotension, and lymphadenopathy Enteric findings include abdominal tenderness with or without rebound over McBurney point Rheumatologic involvement\u00a0includes joint effusion, tenderness, or decreased range of movement and may be asymmetric in distribution. Patients with immunosuppression\u00a0and iron-overload states such as hemochromatosis, venous congestion, hemolytic anemia, and cirrhosis are at risk for sepsis. [9] [10] [11]"}
{"id": "article-27956_17", "title": "Yersinia Pseudotuberculosis -- Evaluation", "content": "The laboratory diagnosis of Yersinia pseudotuberculosis requires confirming the presence of\u00a0the organism to support the clinical diagnosis. The acquisition by culture-positive sources such as blood, cerebrospinal fluid, peritoneal fluid, synovial fluid, or other organ-based biopsy\u00a0is confirmatory. [12] [13] Microbiology", "contents": "Yersinia Pseudotuberculosis -- Evaluation. The laboratory diagnosis of Yersinia pseudotuberculosis requires confirming the presence of\u00a0the organism to support the clinical diagnosis. The acquisition by culture-positive sources such as blood, cerebrospinal fluid, peritoneal fluid, synovial fluid, or other organ-based biopsy\u00a0is confirmatory. [12] [13] Microbiology"}
{"id": "article-27956_18", "title": "Yersinia Pseudotuberculosis -- Evaluation", "content": "Yersinia pseudotuberculosis is a gram-negative, coccobacillus that is differentiated by its fermentation of sorbitol and ornithine decarboxylase activity, among other features. The optimum growth occurs on MacConkey medium at 20 to\u00a035 degrees C. Yersinia pseudotuberculosis is aerobic and facultatively anaerobic. It grows slowly on blood and chocolate agar plates. It forms small gray and translucent colonies at 24 to 72 hours. It has a good growth pattern on MacConkey or eosin-methylene blue agar plates but is enhanced noticeably\u00a0at a temperature\u00a0lower than 28 degrees C when it\u00a0becomes motile at 25 degrees C. Yersinia pseudotuberculosis is oxidase-negative, catalase-producing, and urea-splitting, and does not ferment lactose.", "contents": "Yersinia Pseudotuberculosis -- Evaluation. Yersinia pseudotuberculosis is a gram-negative, coccobacillus that is differentiated by its fermentation of sorbitol and ornithine decarboxylase activity, among other features. The optimum growth occurs on MacConkey medium at 20 to\u00a035 degrees C. Yersinia pseudotuberculosis is aerobic and facultatively anaerobic. It grows slowly on blood and chocolate agar plates. It forms small gray and translucent colonies at 24 to 72 hours. It has a good growth pattern on MacConkey or eosin-methylene blue agar plates but is enhanced noticeably\u00a0at a temperature\u00a0lower than 28 degrees C when it\u00a0becomes motile at 25 degrees C. Yersinia pseudotuberculosis is oxidase-negative, catalase-producing, and urea-splitting, and does not ferment lactose."}
{"id": "article-27956_19", "title": "Yersinia Pseudotuberculosis -- Evaluation -- Stool", "content": "Isolation from stool is difficult given the slow growth pattern. Stool culture yield may be increased with cold enrichment, special culture media, or alkali treatment.", "contents": "Yersinia Pseudotuberculosis -- Evaluation -- Stool. Isolation from stool is difficult given the slow growth pattern. Stool culture yield may be increased with cold enrichment, special culture media, or alkali treatment."}
{"id": "article-27956_20", "title": "Yersinia Pseudotuberculosis -- Evaluation -- Blood, Peritoneal and Synovial Fluids, and Pharyngeal Exudate", "content": "Might\u00a0yield Yersinia pseudotuberculosis", "contents": "Yersinia Pseudotuberculosis -- Evaluation -- Blood, Peritoneal and Synovial Fluids, and Pharyngeal Exudate. Might\u00a0yield Yersinia pseudotuberculosis"}
{"id": "article-27956_21", "title": "Yersinia Pseudotuberculosis -- Evaluation -- Serology", "content": "Enzyme-linked immunosorbent assay and agglutination tests may be obtained; the antibodies (against the O antigen) may appear soon after the onset of illness and wane over two to six months.\u00a0Hemagglutination reaction tests that detect the\u00a0pili\u00a0of either Yersinia pseudotuberculosis or Yersinia pestis have been developed. Hemagglutination titers of 1:160 or higher suggest a true infection. Cross-reaction between antibodies with\u00a0other organisms may obscure the diagnostic picture. These other organisms include other Yersinia, Brucella, Vibrio, Rickettsia, and Salmonella. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis is a reliable serologic procedure for the diagnosis of Yersinia pseudotuberculosis or Yersinia enterocolitica infection.", "contents": "Yersinia Pseudotuberculosis -- Evaluation -- Serology. Enzyme-linked immunosorbent assay and agglutination tests may be obtained; the antibodies (against the O antigen) may appear soon after the onset of illness and wane over two to six months.\u00a0Hemagglutination reaction tests that detect the\u00a0pili\u00a0of either Yersinia pseudotuberculosis or Yersinia pestis have been developed. Hemagglutination titers of 1:160 or higher suggest a true infection. Cross-reaction between antibodies with\u00a0other organisms may obscure the diagnostic picture. These other organisms include other Yersinia, Brucella, Vibrio, Rickettsia, and Salmonella. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis is a reliable serologic procedure for the diagnosis of Yersinia pseudotuberculosis or Yersinia enterocolitica infection."}
{"id": "article-27956_22", "title": "Yersinia Pseudotuberculosis -- Evaluation", "content": "In patients with mesenteric lymphadenitis, computed tomography (CT) scans or ultrasound may reveal enlarged mesenteric lymph nodes and peritoneal findings including inflammation of the appendix and terminal ileitis. In pneumonic or septic presentations, a chest x-ray may reveal infiltrates suggestive of acute pneumonia.", "contents": "Yersinia Pseudotuberculosis -- Evaluation. In patients with mesenteric lymphadenitis, computed tomography (CT) scans or ultrasound may reveal enlarged mesenteric lymph nodes and peritoneal findings including inflammation of the appendix and terminal ileitis. In pneumonic or septic presentations, a chest x-ray may reveal infiltrates suggestive of acute pneumonia."}
{"id": "article-27956_23", "title": "Yersinia Pseudotuberculosis -- Evaluation", "content": "In the rare Kawasaki disease\u2013like variant, Izumi fever, electrocardiogram (ECG) abnormalities may suggest ischemia if aneurysms compromise coronary artery circulation. These abnormalities are more likely to develop in children.", "contents": "Yersinia Pseudotuberculosis -- Evaluation. In the rare Kawasaki disease\u2013like variant, Izumi fever, electrocardiogram (ECG) abnormalities may suggest ischemia if aneurysms compromise coronary artery circulation. These abnormalities are more likely to develop in children."}
{"id": "article-27956_24", "title": "Yersinia Pseudotuberculosis -- Treatment / Management", "content": "Yersinia pseudotuberculosis infection is usually\u00a0self-limited. More toxic presentations, including septic syndromes or severe dehydration, may require hospitalization. General supportive care is needed. [14] [15] Though antibiotics are not required for\u00a0a mild illness, serious manifestations like sepsis occurring in a patient with immunosuppression or chronic liver disease warrant\u00a0the usage of antibiotics. [2]", "contents": "Yersinia Pseudotuberculosis -- Treatment / Management. Yersinia pseudotuberculosis infection is usually\u00a0self-limited. More toxic presentations, including septic syndromes or severe dehydration, may require hospitalization. General supportive care is needed. [14] [15] Though antibiotics are not required for\u00a0a mild illness, serious manifestations like sepsis occurring in a patient with immunosuppression or chronic liver disease warrant\u00a0the usage of antibiotics. [2]"}
{"id": "article-27956_25", "title": "Yersinia Pseudotuberculosis -- Treatment / Management", "content": "The fluoroquinolone group of drugs was found to be the most effective in the treatment of Y. pseudotuberculosis as per in-vitro and in-vivo murine studies. Antibiotics belonging to\u00a0other classes were unable to inhibit the bacterial growth to a significant extent as compared to fluoroquinolones. [16] [17] [18] Nevertheless, antibiotics like ampicillin, ceftriaxone, doxycycline, and gentamycin have been successful in the treatment of Y. pseudotuberculosis and its complications following previously documented case reports. [19] [20] [21] Exploratory laparotomy may be warranted in patients with complications such as severe GI bleeding, and intestinal obstruction. However, this intervention is not common. [22] [23]", "contents": "Yersinia Pseudotuberculosis -- Treatment / Management. The fluoroquinolone group of drugs was found to be the most effective in the treatment of Y. pseudotuberculosis as per in-vitro and in-vivo murine studies. Antibiotics belonging to\u00a0other classes were unable to inhibit the bacterial growth to a significant extent as compared to fluoroquinolones. [16] [17] [18] Nevertheless, antibiotics like ampicillin, ceftriaxone, doxycycline, and gentamycin have been successful in the treatment of Y. pseudotuberculosis and its complications following previously documented case reports. [19] [20] [21] Exploratory laparotomy may be warranted in patients with complications such as severe GI bleeding, and intestinal obstruction. However, this intervention is not common. [22] [23]"}
{"id": "article-27956_26", "title": "Yersinia Pseudotuberculosis -- Differential Diagnosis", "content": "Appendicitis Pancreatitis Inflammatory bowel\u00a0disease Gastroenteritis Scarlet fever Toxic shock syndrome Leptospirosis", "contents": "Yersinia Pseudotuberculosis -- Differential Diagnosis. Appendicitis Pancreatitis Inflammatory bowel\u00a0disease Gastroenteritis Scarlet fever Toxic shock syndrome Leptospirosis"}
{"id": "article-27956_27", "title": "Yersinia Pseudotuberculosis -- Prognosis", "content": "The majority of cases of Yersinia\u00a0pseudotuberculosis are mild and self-limited. In immunocompromised patients and those with chronic liver disease, the disease can be fatal. [Level 3] [24] [25] These\u00a0patients may develop a severe disease that can lead to sepsis and generalized involvement\u00a0of the intestine.", "contents": "Yersinia Pseudotuberculosis -- Prognosis. The majority of cases of Yersinia\u00a0pseudotuberculosis are mild and self-limited. In immunocompromised patients and those with chronic liver disease, the disease can be fatal. [Level 3] [24] [25] These\u00a0patients may develop a severe disease that can lead to sepsis and generalized involvement\u00a0of the intestine."}
{"id": "article-27956_28", "title": "Yersinia Pseudotuberculosis -- Complications", "content": "Reactive arthritis [26] Septic arthritis [27] Uveitis [28] Acute tubulointerstitial nephritis [29] [30] Terminal ileitis Severe GI bleeding Intussusception Intestinal abscess [22] Intestinal obstruction [23] Sepsis Death", "contents": "Yersinia Pseudotuberculosis -- Complications. Reactive arthritis [26] Septic arthritis [27] Uveitis [28] Acute tubulointerstitial nephritis [29] [30] Terminal ileitis Severe GI bleeding Intussusception Intestinal abscess [22] Intestinal obstruction [23] Sepsis Death"}
{"id": "article-27956_29", "title": "Yersinia Pseudotuberculosis -- Postoperative and Rehabilitation Care", "content": "The diarrhea, fever, and anorexia may last a few days or weeks and thus the patient should be kept NPO (nil per os). IV hydration is recommended during this time period.", "contents": "Yersinia Pseudotuberculosis -- Postoperative and Rehabilitation Care. The diarrhea, fever, and anorexia may last a few days or weeks and thus the patient should be kept NPO (nil per os). IV hydration is recommended during this time period."}
{"id": "article-27956_30", "title": "Yersinia Pseudotuberculosis -- Consultations", "content": "Consult gastroenterology, or surgery if invasive diagnostic or therapeutic interventions are warranted. For unusual presentations, rheumatologic, dermatologic, or ocular complications, additional consultation with an infectious disease specialist should be considered.", "contents": "Yersinia Pseudotuberculosis -- Consultations. Consult gastroenterology, or surgery if invasive diagnostic or therapeutic interventions are warranted. For unusual presentations, rheumatologic, dermatologic, or ocular complications, additional consultation with an infectious disease specialist should be considered."}
{"id": "article-27956_31", "title": "Yersinia Pseudotuberculosis -- Deterrence and Patient Education", "content": "The patient should be educated on food hygiene and the fact that the organism is cold tolerant. There is no vaccine available.", "contents": "Yersinia Pseudotuberculosis -- Deterrence and Patient Education. The patient should be educated on food hygiene and the fact that the organism is cold tolerant. There is no vaccine available."}
{"id": "article-27956_32", "title": "Yersinia Pseudotuberculosis -- Pearls and Other Issues", "content": "Yersinia pseudotuberculosis is caused by a cold-tolerant bacterium and is a rare\u00a0cause of foodborne disease. It can present with self-limited enterocolitis or pseudoappendicitis. Even though the mortality rate is low in healthy people, it can be fatal in immunocompromised patients and those with iron overload. Treatment for severe disease is with fluoroquinolones, beta-lactams, and aminoglycosides, usually used\u00a0as a combination therapy.", "contents": "Yersinia Pseudotuberculosis -- Pearls and Other Issues. Yersinia pseudotuberculosis is caused by a cold-tolerant bacterium and is a rare\u00a0cause of foodborne disease. It can present with self-limited enterocolitis or pseudoappendicitis. Even though the mortality rate is low in healthy people, it can be fatal in immunocompromised patients and those with iron overload. Treatment for severe disease is with fluoroquinolones, beta-lactams, and aminoglycosides, usually used\u00a0as a combination therapy."}
{"id": "article-27956_33", "title": "Yersinia Pseudotuberculosis -- Enhancing Healthcare Team Outcomes", "content": "Patients with Yersinia pseudotuberculosis infection should be managed by an interprofessional team approach.  Because the infection can mimic many other disorders, consultation with an infectious\u00a0disease specialist, a gastroenterologist, and a surgeon should be sought. [Level 3] [14] [27] Healthcare workers at all levels should be educating the public on food hygiene and the proper cooking of food. Nurses are often the last to see the patients in the emergency department and at discharge and are in a prime position to educate the patient\u00a0and the family about proper food practices. The nurse should also educate the patient on the signs and symptoms of the infection so that the patient seeks immediate care.", "contents": "Yersinia Pseudotuberculosis -- Enhancing Healthcare Team Outcomes. Patients with Yersinia pseudotuberculosis infection should be managed by an interprofessional team approach.  Because the infection can mimic many other disorders, consultation with an infectious\u00a0disease specialist, a gastroenterologist, and a surgeon should be sought. [Level 3] [14] [27] Healthcare workers at all levels should be educating the public on food hygiene and the proper cooking of food. Nurses are often the last to see the patients in the emergency department and at discharge and are in a prime position to educate the patient\u00a0and the family about proper food practices. The nurse should also educate the patient on the signs and symptoms of the infection so that the patient seeks immediate care."}
{"id": "article-27956_34", "title": "Yersinia Pseudotuberculosis -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Yersinia Pseudotuberculosis -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}